FR2850570B1 - Composition a base de vesicules lamellaires lipidiques incorporant au moins un derive de la famille du ceramide 7 et/ou 5.5, utilisation pour ameliorer la fonction barriere des epidermes - Google Patents

Composition a base de vesicules lamellaires lipidiques incorporant au moins un derive de la famille du ceramide 7 et/ou 5.5, utilisation pour ameliorer la fonction barriere des epidermes

Info

Publication number
FR2850570B1
FR2850570B1 FR0301059A FR0301059A FR2850570B1 FR 2850570 B1 FR2850570 B1 FR 2850570B1 FR 0301059 A FR0301059 A FR 0301059A FR 0301059 A FR0301059 A FR 0301059A FR 2850570 B1 FR2850570 B1 FR 2850570B1
Authority
FR
France
Prior art keywords
epiderms
ceramide
family
derivative
improve
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR0301059A
Other languages
English (en)
Other versions
FR2850570A1 (fr
Inventor
Melanie Chopart
Isabelle Castiel
Jean Thierry Simonnet
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
LOreal SA
Original Assignee
LOreal SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by LOreal SA filed Critical LOreal SA
Priority to FR0301059A priority Critical patent/FR2850570B1/fr
Priority to EP04290063A priority patent/EP1443108A3/fr
Priority to US10/766,016 priority patent/US7169382B2/en
Priority to JP2004023472A priority patent/JP4108618B2/ja
Publication of FR2850570A1 publication Critical patent/FR2850570A1/fr
Application granted granted Critical
Publication of FR2850570B1 publication Critical patent/FR2850570B1/fr
Priority to US11/634,078 priority patent/US20070148771A1/en
Priority to JP2007126007A priority patent/JP2007246538A/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06Animal cells or tissues; Human cells or tissues
    • C12N5/0697Artificial constructs associating cells of different lineages, e.g. tissue equivalents
    • C12N5/0698Skin equivalents
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00Specific components of cell culture medium
    • C12N2500/30Organic components
    • C12N2500/36Lipids
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00Specific components of cell culture medium
    • C12N2500/30Organic components
    • C12N2500/38Vitamins
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2502/00Coculture with; Conditioned medium produced by
    • C12N2502/09Coculture with; Conditioned medium produced by epidermal cells, skin cells, oral mucosa cells
    • C12N2502/094Coculture with; Conditioned medium produced by epidermal cells, skin cells, oral mucosa cells keratinocytes
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2502/00Coculture with; Conditioned medium produced by
    • C12N2502/13Coculture with; Conditioned medium produced by connective tissue cells; generic mesenchyme cells, e.g. so-called "embryonic fibroblasts"
    • C12N2502/1323Adult fibroblasts

Landscapes

  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Cell Biology (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
FR0301059A 2003-01-30 2003-01-30 Composition a base de vesicules lamellaires lipidiques incorporant au moins un derive de la famille du ceramide 7 et/ou 5.5, utilisation pour ameliorer la fonction barriere des epidermes Expired - Fee Related FR2850570B1 (fr)

Priority Applications (6)

Application Number Priority Date Filing Date Title
FR0301059A FR2850570B1 (fr) 2003-01-30 2003-01-30 Composition a base de vesicules lamellaires lipidiques incorporant au moins un derive de la famille du ceramide 7 et/ou 5.5, utilisation pour ameliorer la fonction barriere des epidermes
EP04290063A EP1443108A3 (fr) 2003-01-30 2004-01-09 Procédés de préparation d'un épiderme reconstruit supplémenté en céramide 7 ou 5.5, composition à base de vésicules lamellaires lipidiques incorporant un dérivé du céramide 7 et/ou 5.5 et son utilisation
US10/766,016 US7169382B2 (en) 2003-01-30 2004-01-29 Reconstructed epidermis/skin equivalent comprising a ceramide 7 and /or 5.5 and lipid lamellar vesicular compositions comprising ceramide 7 and/or 5.5 compounds
JP2004023472A JP4108618B2 (ja) 2003-01-30 2004-01-30 セラミド7及び/又は5.5が補填された再構築表皮の調製方法、セラミド7及び/又は5.5ファミリーの少なくとも一の誘導体が導入されたラメラ状脂質小胞体をベースとする組成物、及びその用途
US11/634,078 US20070148771A1 (en) 2003-01-30 2006-12-06 Reconstructed epidermis/skin equivalent comprising a ceramide 7 and/or 5.5 and lipid lamellar vesicular compositions comprising ceramide 7 and/or 5.5 compounds
JP2007126007A JP2007246538A (ja) 2003-01-30 2007-05-10 セラミド7及び/又は5.5が補填された再構築表皮の調製方法、セラミド7及び/又は5.5ファミリーの少なくとも一の誘導体が導入されたラメラ状脂質小胞体をベースとする組成物、及びその用途

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0301059A FR2850570B1 (fr) 2003-01-30 2003-01-30 Composition a base de vesicules lamellaires lipidiques incorporant au moins un derive de la famille du ceramide 7 et/ou 5.5, utilisation pour ameliorer la fonction barriere des epidermes

Publications (2)

Publication Number Publication Date
FR2850570A1 FR2850570A1 (fr) 2004-08-06
FR2850570B1 true FR2850570B1 (fr) 2005-03-11

Family

ID=32696219

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0301059A Expired - Fee Related FR2850570B1 (fr) 2003-01-30 2003-01-30 Composition a base de vesicules lamellaires lipidiques incorporant au moins un derive de la famille du ceramide 7 et/ou 5.5, utilisation pour ameliorer la fonction barriere des epidermes

Country Status (1)

Country Link
FR (1) FR2850570B1 (fr)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2652002B1 (fr) * 1989-09-21 1991-11-29 Oreal Nouveaux composes lipidiques derives des sphingosines, leur procede de preparation et leurs applications, notamment en cosmetique et en dermopharmacie.
FR2694884B1 (fr) * 1992-08-03 1996-10-18 Oreal Composition formee d'une dispersion aqueuse de vesicules de lipides amphiphiles non-ioniques stabilisees.
JP4046426B2 (ja) * 1998-11-17 2008-02-13 花王株式会社 セラミド誘導体及びそれを含有する皮膚化粧料
FR2811556B1 (fr) * 2000-07-11 2002-09-06 Oreal Composition comprenant un precurseur de ceramides, utilisation pour ameliorer l'epiderme naturel ou reconstruit , equivalent de peau obtenu

Also Published As

Publication number Publication date
FR2850570A1 (fr) 2004-08-06

Similar Documents

Publication Publication Date Title
DK1180133T3 (da) Sure, milde, flydende rensesammensætninger
IT1321270B1 (it) Unita' dosatrice.
MA26968A1 (fr) Compositions pharmaceutiques contenant du maleate d'amlodipine.
TWI345985B (en) Mild, moisturizing cleansing compositions
IT1316448B1 (it) Dispositivo per l'assorbimento di vibrazioni, particolarmente percalzature od attrezzi sportivi.
WO2006056696A3 (fr) 2-alcoxy-3,4,5-trihydroxy-alkylamides, leur preparation, compositions les contenant et utilisation
DE60133808D1 (de) Enganliegende, flüssigkeitsaustritt-widerstandsfähige damenbinde
EP1889642A3 (fr) Compositions cosmétiques associant un dérivé C-glycoside et un dérivé N-acylaminoamide
FR2844453B1 (fr) Utilisation de pre-biotiques pour la prevention de l'installation du diabete de type ii
FR2879459B1 (fr) Composition comprenant de l'adapalene solubilise avec des cyclodextrines
FR2863878B1 (fr) Utilisation d'ecdysteroides pour la preparation de compositions dermathologiques ou cosmetiques anti-chute de cheveux.
FR2833566B1 (fr) Planche de glisse creuse avec des masselottes d'inertie
FR2850570B1 (fr) Composition a base de vesicules lamellaires lipidiques incorporant au moins un derive de la famille du ceramide 7 et/ou 5.5, utilisation pour ameliorer la fonction barriere des epidermes
AU2003288974A8 (en) Compositions comprised of normal propyl bromide and 1,1,1,3,3-pentafluorobutane and uses thereof
ITMI20011837A0 (it) Estratti dal fungus guignardia sp., loro impiego nelle composizioni farmaceutiche,nuovo composto isolato dall'estratto del fungus guignardia
DZ2548A1 (fr) Compositions de sertraline solubilisée.
DE60038569D1 (de) Trainingsgerät für den taillenbereich
ITMI20020624A0 (it) Composizioni ad attivita' biostimolante
Schneider Försäljning och marknadsföring av medicintekniska engångsprodukter mot den svenska sjukhusmarknaden: En fallstudie av företaget Louis Gibeck AB
FR2827765B1 (fr) Composition a base de vesicules lamellaires lipidiques incorporant au moins un compose a base de dhea
FR2835394B1 (fr) Machine pour l'ecimage des melons
ITGE20000133A0 (it) Apparecchiatura biomedicale per la riabilitazione vestibolare tramiterealta' virtuale.
FR2818131B1 (fr) Composition cosmetique comprenant de l'heparanase
UA8173S (uk) Обгортка для морозива «навколо світу»
FR2810254B1 (fr) Element d'habillage pour jouet, et jeu de table du type baby-foot pourvu d'au moins un tel element

Legal Events

Date Code Title Description
ST Notification of lapse

Effective date: 20091030